Media, Video 08 Jul 2022 VIDEO | ShareCafe ‘Hidden Gems’ Webinar – July 2022 Orthocell CEO and Managing Director, Paul Anderson, recently participated in the ShareCafe Small Cap ‘Hidden Gems’ Webinar. Orthocell
Media, Video 12 May 2022 Remplirâ„¢ Channel 7 News feature Clinical trial participant Damian Hall was featured in a national news story by Channel 7 News Reporter, Alison Fan, to… Orthocell
Media, Video 22 Mar 2022 VIDEO | Proactive Investors – March 2022 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in… Orthocell
Media 13 Dec 2021 RADIO INTERVIEW | Bulls N’ Bears Report Orthocell (ASX $OCC) MD, Paul Anderson, was interviewed by Matt Birney on the Bulls N’ Bears Report about our latest… Orthocell
Media 09 Dec 2021 The West Australian | Orthocell’s tendon injury treatment a game-changer, clinical trial finds Orthocell (ASX $OCC) has been featured in The West Australian in a story titled, “Orthocell’s tendon injury treatment a game-changer, clinical trial… Orthocell
Media 15 Sep 2021 Orthocell (ASX:OCC) announces positive data on CelGro collagen rope for ACL repair Orthocell has been featured in The Market Herald, following our announcement of positive data from a pre-clinical study for anterior… Orthocell
Media 07 Sep 2021 Orthocell (ASX:OCC) granted patents in Canada and Hong Kong for CelGro Orthocell has been featured in The Market Herald, following our announcement of patents granted in Canada and Hong Kong for… Orthocell
Media, Video 02 Sep 2021 Video | Proactive Investors – September 2021 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in… Orthocell
Media 31 Aug 2021 Orthocell’s (ASX:OCC) final patient completes treatment in tendon regeneration study Orthocell has been featured in The Market Herald, highlighting the follow-up announcement from our OrthoATI™ rotator cuff tendon regeneration study. Orthocell
Media, Video 03 Aug 2021 Video | Proactive Investors – Orthocell highlights potential for CelGro in treatment of lymphedema Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGroâ„¢ with… Orthocell
